Semin Thromb Hemost 2010; 36(4): 444-451
DOI: 10.1055/s-0030-1254053
© Thieme Medical Publishers

Snakebite Doesn't Cause Disseminated Intravascular Coagulation: Coagulopathy and Thrombotic Microangiopathy in Snake Envenoming

Geoffrey K. Isbister1
  • 1Discipline of Clinical Pharmacology, University of Newcastle, and Department of Clinical Toxicology and Pharmacology, Calvary Mater Newcastle, Waratah NSW, Australia
Further Information

Publication History

Publication Date:
07 July 2010 (online)

ABSTRACT

The most common coagulopathy associated with snake envenoming worldwide is venom-induced consumption coagulopathy (VICC), which results from activation of the coagulation pathway by snake toxins including thrombin-like enzymes, prothrombin activators, and factor X activators. VICC has often been likened to disseminated intravascular coagulation (DIC) because of the elevated D-dimer, prolonged prothrombin time, and low fibrinogen. However, VICC is not characterized by other important features of DIC, such as evidence of systemic microthrombi and end-organ failure. In addition, the time course of VICC differs with rapid onset and resolution, and the mechanism of initiation of coagulation activation differs because thrombin generation in DIC is mediated by the tissue factor/factor VIIa pathway. In a proportion of patients with VICC, a clinical syndrome consistent with thrombotic microangiopathy has been reported and is characterized by acute renal failure, thrombocytopenia, and microangiopathic hemolytic anemia. This thrombotic microangiopathy appears to only occur in conjunction with VICC but in several different snakes worldwide including vipers and elapids. Consistent with thrombotic microangiopathy, it progresses despite the resolution of the coagulopathy, suggesting a distinct but related process. The existence of the overlapping clinical syndromes of VICC and thrombotic microangiopathy in snake envenoming is the likely reason for the mistaken idea that snakebite causes DIC.

REFERENCES

  • 1 Isbister G K, Currie B J, Little M, Daly F F, Isbister J P. Coagulopathy from tiger snake envenoming and its treatment.  Pathology. 2002;  34 588-590
  • 2 Damus P S, Salzman E W. Disseminated intravascular coagulation.  Arch Surg. 1972;  104 262-265
  • 3 Levi M. Disseminated intravascular coagulation.  Crit Care Med. 2007;  35 2191-2195
  • 4 Warrell D A, Pope H M, Prentice C R. Disseminated intravascular coagulation caused by the carpet viper (Echis carinatus): trial of heparin.  Br J Haematol. 1976;  33 335-342
  • 5 Masci P P, Rowe E A, Whitaker A N, de Jersey J. Fibrinolysis as a feature of disseminated intravascular coagulation (DIC) after Pseudonaja textilis textilis envenomation.  Thromb Res. 1990;  59 859-870
  • 6 Lifshitz M, Kapelushnik J, Ben Harosh M, Sofer S. Disseminated intravascular coagulation after Cerastes vipera envenomation in a 3-year-old child: a case report.  Toxicon. 2000;  38 1593-1598
  • 7 Miao Y N, Chen M C, Huang Z. Clinical observation on treatment of snake bite induced disseminated intravascular coagulation by qinwen baidu decoction [in Chinese].  Zhongguo Zhong Xi Yi Jie He Za Zhi. 2003;  23 590-592
  • 8 Tin Na Swe, Myint Lwin, Khin Ei Han, Tin Tun, Tun Pe. Heparin therapy in Russell's viper bite victims with disseminated intravascular coagulation: a controlled trial.  Southeast Asian J Trop Med Public Health. 1992;  23 282-287
  • 9 Taylor Jr F B, Toh C H, Hoots W K, Wada H, Levi M. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation.  Thromb Haemost. 2001;  86 1327-1330
  • 10 Isbister G K. Procoagulant snake toxins: laboratory studies, diagnosis, and understanding snakebite coagulopathy.  Semin Thromb Hemost. 2009;  35 93-103
  • 11 Swenson S, Markland Jr F S. Snake venom fibrin(ogen)olytic enzymes.  Toxicon. 2005;  45 1021-1039
  • 12 Warrell D A, Davidson N M, Greenwood B M et al.. Poisoning by bites of the saw-scaled or carpet viper (Echis carinatus) in Nigeria.  Q J Med. 1977;  46 33-62
  • 13 Lalloo D G, Trevett A J, Owens D et al.. Coagulopathy following bites by the Papuan taipan (Oxyuranus scutellatus canni).  Blood Coagul Fibrinolysis. 1995;  6 65-72
  • 14 Tans G, Rosing J. Snake venom activators of factor X: an overview.  Haemostasis. 2001;  31 225-233
  • 15 Sano-Martins I S, Tomy S C, Campolina D et al.. Coagulopathy following lethal and non-lethal envenoming of humans by the South American rattlesnake (Crotalus durissus) in Brazil.  QJM. 2001;  94 551-559
  • 16 Morling A C, Marshall L R, Herrmann R P. Thrombocytopenia after brown snake envenomation.  Med J Aust. 1989;  151 627-628
  • 17 Offerman S R, Barry J D, Schneir A, Clark R F. Biphasic rattlesnake venom-induced thrombocytopenia.  J Emerg Med. 2003;  24 289-293
  • 18 Isbister G K, Duffull S B, Brown S G. Failure of antivenom to improve recovery in Australian snakebite coagulopathy.  QJM. 2009;  102 563-568
  • 19 Levi M. Current understanding of disseminated intravascular coagulation.  Br J Haematol. 2004;  124 567-576
  • 20 Levi M, van der Poll T, ten Cate H. Tissue factor in infection and severe inflammation.  Semin Thromb Hemost. 2006;  32 33-39
  • 21 Isbister G K, Scorgie F, Brown S GA, O'Leary M A, Seldon M, Lincz L. Coagulation factor deficiencies associated with venom induced consumption coagulopathy in Australian snake envenoming [abstract].  Clin Toxicol. 2009;  47 462
  • 22 Isbister G K, Little M, Cull G et al.. Thrombotic microangiopathy from Australian brown snake (Pseudonaja) envenoming.  Intern Med J. 2007;  37 523-528
  • 23 Chugh K S, Aikat B K, Sharma B K, Dash S C, Mathew M T, Das K C. Acute renal failure following snakebite.  Am J Trop Med Hyg. 1975;  24 692-697
  • 24 Varagunam T, Panabokke R G. Bilateral cortical necrosis of the kidneys following snakebite.  Postgrad Med J. 1970;  46 449-451
  • 25 Harris A R, Hurst P E, Saker B M. Renal failure after snake bite.  Med J Aust. 1976;  2 409-411
  • 26 Chugh K S, Pal Y, Chakravarty R N et al.. Acute renal failure following poisonous snakebite.  Am J Kidney Dis. 1984;  4 30-38
  • 27 Schneemann M, Cathomas R, Laidlaw S T, El Nahas A M, Theakston R D, Warrell D A. Life-threatening envenoming by the Saharan horned viper (Cerastes cerastes) causing micro-angiopathic haemolysis, coagulopathy and acute renal failure: clinical cases and review.  QJM. 2004;  97 717-727
  • 28 Cobcroft R G, Williams A, Cook D, Williams D J, Masci P. Hemolytic uremic syndrome following taipan envenomation with response to plasmapheresis.  Pathology. 1997;  29 399-402
  • 29 Fakhouri F, Fremeaux-Bacchi V. Does hemolytic uremic syndrome differ from thrombotic thrombocytopenic purpura?.  Nat Clin Pract Nephrol. 2007;  3 679-687
  • 30 Keyler D E. Envenomation by the lowland viper (Proatheris superciliaris): severe case profile documentation.  Toxicon. 2008;  52 836-841
  • 31 Forzley B R, Clark W F. TTP/HUS and prognosis: the syndrome and the disease(s).  Kidney Int Suppl. 2009;  (112) S59-S61
  • 32 Caprioli J, Noris M, Brioschi S et al.. Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome.  Blood. 2006;  108 1267-1279
  • 33 Kruk C, Sprivulis P, Jelinek G A. Two cases of acute renal failure after brown snake bite.  Emerg Med. 1994;  6 17-20
  • 34 Acott C J. Acute renal failure after envenomation by the common brown snake.  Med J Aust. 1988;  149 709-710
  • 35 White J, Fassett R. Acute renal failure and coagulopathy after snakebite.  Med J Aust. 1983;  2 142-143
  • 36 Schapel G J, Utley D, Wilson G C. Envenomation by the Australian common brown snake—Pseudonaja (Demansia) textilis textilis .  Med J Aust. 1971;  1 142-144
  • 37 Buckley N, Dawson A H. Unusual results of brown snake envenomation.  Med J Aust. 1986;  158 866
  • 38 Date A, Pulimood R, Jacob C K, Kirubakaran M G, Shastry J C. Haemolytic-uraemic syndrome complicating snake bite.  Nephron. 1986;  42 89-90
  • 39 Warrell D A, Ormerod L D, Davidson N M. Bites by puff-adder (Bitis arietans) in Nigeria, and value of antivenom.  BMJ. 1975;  4 697-700
  • 40 Porath A, Gilon D, Schulchynska-Castel H, Shalev O, Keynan A, Benbassat J. Risk indicators after envenomation in humans by Echis coloratus (mid-east saw scaled viper).  Toxicon. 1992;  30 25-32
  • 41 Gomez H F, Dart R C. Clinical toxicology of snakebite in North America. In: Clinical Toxicology of Animal Venoms and Poisons. 1st ed. Boca Raton, FL; CRC Press 1995: 619-644
  • 42 Gutierrez J M. Clinical toxicology of snakebite in Central America. In: Clinical Toxicology of Animal Venoms and Poisons. 1st ed Boca Raton, FL; CRC Press 1995: 645-665
  • 43 Fan H W, Cardoso J L. Clinical toxicology of snake bites in South America. In: Clinical Toxicology of Animal Venoms and Poisons. 1st ed Boca Raton, FL; CRC Press 1995: 667-668
  • 44 Otero-Patiño R. Epidemiological, clinical and therapeutic aspects of Bothrops asper bites.  Toxicon. 2009;  54 998-1011
  • 45 Isbister G K, Williams V, Brown S G, White J, Currie B J. Clinically applicable laboratory end-points for treating snakebite coagulopathy.  Pathology. 2006;  38 568-572
  • 46 de Silva A, Wijekoon A S, Jayasena L et al.. Haemostatic dysfunction and acute renal failure following envenoming by Merrem's hump-nosed viper (Hypnale hypnale) in Sri Lanka: first authenticated case.  Trans R Soc Trop Med Hyg. 1994;  88 209-212

Geoff IsbisterM.D. 

Department of Clinical Toxicology, Calvary Mater Newcastle Hospital

Edith St, Waratah NSW 2298, Australia

Email: geoffrey.isbister@newcastle.edu.au